For Immediate Release:
January 23, 2018
Office of The Attorney General
Gurbir S. Grewal,
Division of Consumer Affairs
For Further Information Contact:|
Sharon Lauchaire, 609-292-4791
Proposed Regulation -
Prescription Monitoring Program: Gabapentin Reporting
NEWARK – The Division of Consumer Affairs (Division) is proposing to amend the Prescription Monitoring Program (PMP) rules at N.J.A.C. 13:45A to require New Jersey licensed pharmacies and registered out-of-State pharmacies to electronically transmit information to the Division about prescriptions filled for gabapentin.
The proposed regulations, and information on how to submit a comment by March 3, 2018 can be viewed
Follow the Division of Consumer Affairs on its
Follow the New Jersey Attorney General’s Office online at Twitter, Facebook, Instagram & YouTube. The social media links provided are for reference only. The New Jersey Attorney General’s Office does not endorse any non-governmental websites, companies or applications.
Last Modified: 1/25/2018 10:03 AM